Cybin Inc. (CYBN)
NYSEAMERICAN: CYBN · Real-Time Price · USD
6.43
+0.35 (5.76%)
At close: Oct 6, 2025, 4:00 PM EDT
6.45
+0.02 (0.31%)
After-hours: Oct 6, 2025, 5:17 PM EDT
Cybin Market Cap
Cybin has a market cap or net worth of $162.02 million as of October 6, 2025. Its market cap has increased by 4.48% in one year.
Market Cap
162.02M
Enterprise Value
81.53M
1-Year Change
4.48%
Ranking
Category
Stock Price
$6.43
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $162.02M, an increase of 77.86%. That is a compound annual growth rate of 12.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 153.20M | -13.16% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | 195.64M | 114.76% |
| Nov 11, 2020 | 91.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |